MCM
TDACW

Moore Capital Management’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Moore Capital Management’s Portfolio TDACW Stock Details TDACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6K Hold
50,000
– – ﹤0.01% 622
2025
Q4 		$15.5K Hold
50,000
– – ﹤0.01% 641
2025
Q3 		$14.5K Hold
50,000
– – ﹤0.01% 595
2025
Q2 		$14.5K Buy
+50,000
New +$10.3K ﹤0.01% 514

Other funds holding TDACW

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Moore Capital Management's TDACW Position: Q1 2026 in Review

Moore Capital Management held its Translational Development Acquisition Corp Warrants (TDACW) position steady in Q1 2026 at 50,000 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #622.

Moore Capital Management first reported a position in TDACW in Q2 2025 and has held it in 4 quarters since. The position peaked at $15.5K in Q4 2025. 32 funds tracked by Wall St. Rank hold TDACW as of Q1 2026.

  • Moore Capital Management held 50,000 shares of Translational Development Acquisition Corp Warrants worth $6K as of Q1 2026.
  • Moore Capital Management left its Translational Development Acquisition Corp Warrants share count unchanged in Q1 2026.
  • Translational Development Acquisition Corp Warrants made up ﹤0.01% of Moore Capital Management's portfolio in Q1 2026, its #622 holding.
  • Moore Capital Management first reported a position in Translational Development Acquisition Corp Warrants in Q2 2025 and has held it in 4 quarters since.
  • Moore Capital Management's Translational Development Acquisition Corp Warrants position peaked at $15.5K in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q1 2026.

Based on Moore Capital Management's 13F filing for Q1 2026, filed 15 May 2026.